HIGGINS JOHN L
SEC CIK 1208906 · EDGAR
BoughtSold
Most active insiders at OABI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FOEHR MATTHEW W | Pres, CEO, Dir | — | $143.5K |
| 2 | HIGGINS JOHN L | Dir | $107.7K | — |
| 3 | GUSTAFSON KURT A | CFO, Executive VP, Fin | — | $84.7K |
| 4 | Berkman Charles S | CLO | — | $54.9K |
| 5 | Crouse Steven C. | Dir | — | — |
| 6 | Gotwals Philip J | Dir | — | — |
| 7 | Cochran Jennifer R. | Dir | — | — |
| 8 | Bertozzi Carolyn R | Dir | — | — |
| 9 | Love Steven | Dir | — | — |
Transactions 57
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-18 16:30 | 2026-06-17 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | — | +20.0K | 2.96M | +0.7% | — |
| D | 2026-01-30 | 2026-01-30 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | — | +13.2K | 2.94M | +0.4% | — |
| M | 2025-11-10 | 2025-11-06+ | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | P - Purchase | $1.39 | +77.3K | 2.93M | +3% | +$107.7K |
| D | 2025-11-03 | 2025-10-30 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +1,640 | 66.9K | +3% | $0 |
| D | 2025-08-11 | 2025-08-07 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | M - OptEx | $21.84 | +5,040 | 65.2K | +8% | +$110.1K |
| D | 2025-06-18 | 2025-06-17 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | — | +20.0K | 2.85M | +0.7% | — |
| 2025-05-13 | 2025-05-12 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | P - Purchase | $1.44 | +65.0K | 2.83M | +2% | +$93.6K | |
| D | 2025-05-05 | 2025-05-01 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | M - OptEx | $21.84 | +12.0K | 60.2K | +25% | +$262.1K |
| 2025-03-21 | 2025-03-21 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | P - Purchase | $2.28 | +4,000 | 2.77M | +0.1% | +$9,120 | |
| 2025-03-20 | 2025-03-20 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | P - Purchase | $2.35 | +125.8K | 2.76M | +5% | +$295.5K | |
| D | 2025-01-30 | 2025-01-30 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | — | +13.2K | 2.64M | +0.5% | — |
| D | 2024-10-28 | 2024-10-24 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +1,462 | 48.2K | +3% | $0 |
| D | 2024-09-16 | 2024-09-12 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | M - OptEx | $22.95 | +6,000 | 48.6K | +14% | +$137.7K |
| D | 2024-09-16 | 2024-09-12 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | F - Tax | $73.20 | -1,874 | 46.7K | -4% | -$137.2K |
| D | 2024-07-10 | 2024-07-08 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | M - OptEx | $22.95 | +6,000 | 42.6K | +16% | +$137.7K |
| D | 2024-06-21 | 2024-06-18 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | — | +20.0K | 2.62M | +0.8% | — |
| D | 2024-05-16 | 2024-05-14 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | S - Sale+OE | $83.84 | -4,000 | 36.6K | -10% | -$335.4K |
| D | 2024-05-16 | 2024-05-14 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | M - OptEx | $22.95 | +4,000 | 40.6K | +11% | +$91.8K |
| A | 2024-04-23 | 2022-11-01 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | A - Grant | — | +2.43M | 2.60M | +1,379% | — |
| D | 2024-01-31 | 2024-01-30 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | — | +13.2K | 2.35M | +0.6% | — |
| D | 2023-10-30 | 2023-10-26 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +1,625 | 36.6K | +5% | $0 |
| DM | 2023-06-27 | 2022-12-28+ | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | F - Tax | $3.36 | +83.7K | 2.40M | +4% | +$281.5K |
| D | 2023-05-25 | 2023-05-23 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | S - Sale+OE | $4.05 | -9,000 | 2.46M | -0.4% | -$36.5K |
| D | 2023-05-25 | 2023-05-23 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | $3.68 | +9,000 | 2.47M | +0.4% | +$33.1K |
| D | 2023-05-23 | 2023-05-19 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | $3.68 | +1,000 | 2.46M | +0.0% | +$3,680 |
| D | 2023-05-23 | 2023-05-19 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | S - Sale+OE | $4.05 | -1,000 | 2.46M | -0.0% | -$4,050 |
| D | 2023-05-19 | 2023-05-18 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | S - Sale+OE | $3.89 | -50.0K | 2.46M | -2% | -$194.5K |
| D | 2023-05-19 | 2023-05-18 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | $3.68 | +50.0K | 2.51M | +2% | +$184.0K |
| D | 2023-05-02 | 2023-04-28 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | M - OptEx | $21.85 | +16.0K | 39.4K | +68% | +$349.6K |
| D | 2023-05-02 | 2023-04-28 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | F - Tax | $79.88 | -4,377 | 35.0K | -11% | -$349.6K |
| D | 2023-02-01 | 2023-01-30 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +39.5K | 2.46M | +2% | $0 |
| 2022-12-30 | 2022-12-28 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Dir | F - Tax | $66.29 | -5,289 | 417.7K | -1% | -$350.6K | |
| 2022-12-20 | 2022-12-16 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Dir | S - Sale | $61.87 | -10.0K | 423.0K | -2% | -$618.7K | |
| D | 2022-12-14 | 2022-12-12 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Dir | M - OptEx | $12.78 | +20.0K | 436.9K | +5% | +$255.6K |
| D | 2022-12-14 | 2022-12-12 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Dir | D - Sale to Iss | $64.80 | -3,944 | 433.0K | -0.9% | -$255.6K |
| 2022-12-01 | 2022-11-30 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | F - Tax | $72.90 | -9,803 | 416.9K | -2% | -$714.6K | |
| D | 2022-11-21 | 2022-11-17 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | S - Sale+OE | $78.32 | -10.0K | 416.7K | -2% | -$783.2K |
| D | 2022-11-21 | 2022-11-18 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | M - OptEx | $12.78 | +10.0K | 426.7K | +2% | +$127.8K |
| 2022-11-03 | 2022-11-01 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | A - Grant | $0.00 | +45.9K | 424.7K | +12% | $0 | |
| D | 2022-11-03 | 2022-11-01 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | A - Grant | — | +2.18M | 2.18M | New | — |
| D | 2022-11-03 | 2022-11-02 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Dir | M - OptEx | $2.52 | +246.6K | 2.42M | +11% | +$621.6K |
| D | 2022-10-31 | 2022-10-27 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +338 | 5,840 | +6% | $0 |
| A | 2022-09-22 | 2022-09-16 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | S - Sale | $88.06 | -1,000 | 366.2K | -0.3% | -$88.1K |
| M | 2022-09-16 | 2022-09-15+ | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | S - Sale | $89.61 | -5,000 | 364.2K | -1% | -$448.1K |
| DM | 2022-08-12 | 2022-08-10+ | TECH | Bio-Techne | HIGGINS JOHN L | Dir | S - Sale+OE | $378.80 | -2,504 | 7,106 | -26% | -$948.5K |
| D | 2022-08-12 | 2022-08-10 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | M - OptEx | $66.90 | +3,400 | 8,006 | +74% | +$227.5K |
| 2022-07-06 | 2022-06-30 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | J - Other | $75.84 | +164 | 369.2K | +0.0% | +$12.4K | |
| 2022-06-14 | 2022-06-10 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | A - Grant | $0.00 | +20.4K | 369.0K | +6% | $0 | |
| DM | 2022-06-09 | 2022-06-07+ | TECH | Bio-Techne | HIGGINS JOHN L | Dir | S - Sale+OE | $364.98 | -1,600 | 4,606 | -26% | -$584.0K |
| DM | 2022-06-09 | 2022-06-07+ | TECH | Bio-Techne | HIGGINS JOHN L | Dir | M - OptEx | $66.90 | +1,600 | 5,206 | +44% | +$107.0K |
| D | 2022-05-10 | 2022-05-09 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | M - OptEx | $21.92 | +8,000 | 348.6K | +2% | +$175.4K |
| M | 2022-02-16 | 2022-02-15 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | F - Tax | $123.68 | -5,923 | 344.6K | -2% | -$732.6K |
| M | 2022-01-28 | 2022-01-26 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | A - Grant | $0.00 | +23.2K | 358.3K | +7% | $0 |
| M | 2022-01-28 | 2022-01-26 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | F - Tax | $113.68 | -9,243 | 355.2K | -3% | -$1.05M |
| 2021-11-12 | 2021-11-12 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | S - Sale | $160.50 | -3,000 | 335.1K | -0.9% | -$481.5K | |
| D | 2021-11-01 | 2021-10-28 | TECH | Bio-Techne | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +194 | 4,606 | +4% | $0 |
| 2021-07-02 | 2021-06-30 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | CEO, Dir | J - Other | $85.91 | +247 | 338.1K | +0.1% | +$21.2K |
Purchase Sale Sale after option exercise All abbreviations